Pharvaris Shareholders Approve 2025 Accounts and Renew Board Authorities at 2026 AGM
at www.tipranks.com (Fri, 26-Jun 11:47 AM)
Analyst Reiterates Buy on Deucrictibant’s Strong HAE Profile and Lifts Price Target to $46
at www.tipranks.com (Thu, 25-Jun 6:56 AM)
